FDA Inspection 872676 — Pharmakon Pharmaceuticals, Inc.

Pharmakon Pharmaceuticals, Inc. — FEI 3008213711

The FDA completed an inspection of Pharmakon Pharmaceuticals, Inc. on April 8, 2014 in Noblesville, IN. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 8, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Noblesville, IN (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
163321 CFR 211.130(d)Examination of packaging and labeling
172521 CFR 211.134(c)Examinations documented
200721 CFR 211.186(a)Signature and checking of records -- 2 persons
202721 CFR 211.192Investigations of discrepancies, failures
362921 CFR 211.170(b)Reserve samples identified, representative, stored